BioNTech
BNTX
252 hedge funds and large institutions have $4.01B invested in BioNTech in 2023 Q3 according to their latest regulatory filings, with 33 funds opening new positions, 71 increasing their positions, 77 reducing their positions, and 31 closing their positions.
6% more first-time investments, than exits
New positions opened: 33 | Existing positions closed: 31
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
0.01% less ownership
Funds ownership: 15.42% → 15.42% (-0.01%)
0% less funds holding
Funds holding: 253 → 252 (-1)
1% less call options, than puts
Call options by funds: $230M | Put options by funds: $232M
1% less capital invested
Capital invested by funds: $4.05B → $4.01B (-$39.4M)
8% less repeat investments, than reductions
Existing positions increased: 71 | Existing positions reduced: 77
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
+$127M |
| 2 |
UBS AM
Chicago,
Illinois
|
+$43.9M |
| 3 |
Voloridge Investment Management
Jupiter,
Florida
|
+$37.5M |
| 4 |
QOP
Quinn Opportunity Partners
Charlottesville,
Virginia
|
+$27.6M |
| 5 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
+$22.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Artisan Partners
Milwaukee,
Wisconsin
|
-$143M |
| 2 |
Renaissance Technologies
New York
|
-$48M |
| 3 |
Twin Tree Management
Dallas,
Texas
|
-$43.7M |
| 4 |
SEI Investments
Oaks,
Pennsylvania
|
-$22.6M |
| 5 |
SM
Senvest Management
New York
|
-$18.8M |
BNTX Hedge Fund Activity: Q3 2023 in Review
252 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in BioNTech (BNTX) for Q3 2023, worth a combined $4.01B — down 0.97% from $4.05B a quarter earlier.
Buyers outnumbered sellers: 33 funds opened new BNTX positions and 31 closed out — a net gain of 2 holders — while 71 added to existing stakes and 77 trimmed.
The largest buyer was Baillie Gifford & Co, adding an estimated $127M. The largest seller was Artisan Partners, cutting an estimated $143M.
- 252 institutional investors held BioNTech (BNTX) as of Q3 2023, down from 253 in Q2 2023.
- Funds reported $4.01B of BioNTech stock for Q3 2023, down 0.97% quarter-over-quarter.
- 33 funds opened new BioNTech positions in Q3 2023 and 31 closed out, a net change of +2 holders.
- The largest BioNTech buyer in Q3 2023 was Baillie Gifford & Co, an estimated $127M added.
- The largest BioNTech seller in Q3 2023 was Artisan Partners, an estimated $143M sold.
Based on aggregated 13F filings for Q3 2023.